Skip to main content

Reimbursement

By Susan Morse | 10:23 am | September 25, 2015
The five-year model will be tested in seven states starting in January 2017: Arizona, Indiana, Iowa, Mass., Pennsylvania Tennessee and Oregon.
By Healthcare Finance Staff | 06:05 pm | September 24, 2015
Mark T. Bertolini, chairman and CEO of Aetna in Hartford, Connecticut and Joseph R. Swedish, president and CEO of Anthem in Indianapolis, argued before a Senate Judiciary subcommittee on Antitrust, Competition Policy and Consumer Rights on Tuesday that local insurance plans would keep the industry competitive.
By Healthcare Finance Staff | 03:31 pm | September 24, 2015
The National Committee for Quality Assurance has released its newest rankings for health plans in the United States based on clinical and satisfaction scores. 
By Kaiser Health News | 10:02 am | September 24, 2015
The health law's upcoming enrollment period may be its toughest yet, with federal officials promising a vigorous outreach campaign to enroll millions of eligible yet hard-to-reach Americans who have yet to sign up for health insurance.
By Susan Morse | 09:01 am | September 24, 2015
Mark T. Bertolini, chairman and CEO of Aetna in Hartford, Connecticut and Joseph R. Swedish, president and CEO of Anthem in Indianapolis, argued before a Senate Judiciary subcommittee on Antitrust, Competition Policy and Consumer Rights on Tuesday that local insurance plans would keep the industry competitive.
By Kaiser Health News | 10:17 am | September 23, 2015
Forty-six percent of covered workers have a deductible of at least $1,000 this year for single coverage as employers shift to "consumer-directed" plans that give members incentives to seek less-costly care.
By Healthcare Finance Staff | 06:21 pm | September 22, 2015
Earlier this week, Turing Pharmaceutical CEO Martin Shkreli drew sharp criticism after his privately held company boosted the price of AIDS treatment drug Daraprim from a reported $13.50 a tablet to $750.
By Susan Morse | 06:02 pm | September 22, 2015
Earlier this week, Turing Pharmaceutical CEO Martin Shkreli drew sharp criticism after his privately held company boosted the price of AIDS treatment drug Daraprim from a reported $13.50 a tablet to $750.
By Healthcare Finance Staff | 02:38 pm | September 22, 2015
A new consumer website unveiled by the California Department of Insurance hopes to help Californians better shop for healthcare based on both quality and price.
By Healthcare Finance Staff | 02:25 pm | September 22, 2015
According to new data released by the Centers for Medicare and Medicaid Services on Monday, the U.S. government has paid nearly $2.3 billion through July in incentives to close the coverage gap in 2015.